Cite
Diagnostic and Prognostic Value of Lead aVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia.
MLA
Wagener, Max, et al. “Diagnostic and Prognostic Value of Lead AVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia.” The American Journal of Cardiology, vol. 119, no. 7, Apr. 2017, pp. 959–66. EBSCOhost, https://doi.org/10.1016/j.amjcard.2016.11.056.
APA
Wagener, M., Abächerli, R., Honegger, U., Schaerli, N., Prêtre, G., Twerenbold, R., Puelacher, C., Sunier, G., Reddiess, P., Rubini Gimenez, M., Wildi, K., Boeddinghaus, J., Nestelberger, T., Badertscher, P., Sabti, Z., Schmid, R., Leber, R., Widmer, D. F., Shrestha, S., … Reichlin, T. (2017). Diagnostic and Prognostic Value of Lead aVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia. The American Journal of Cardiology, 119(7), 959–966. https://doi.org/10.1016/j.amjcard.2016.11.056
Chicago
Wagener, Max, Roger Abächerli, Ursina Honegger, Nicolas Schaerli, Gil Prêtre, Raphael Twerenbold, Christian Puelacher, et al. 2017. “Diagnostic and Prognostic Value of Lead AVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia.” The American Journal of Cardiology 119 (7): 959–66. doi:10.1016/j.amjcard.2016.11.056.